Colchicine-treated Familial Mediterranean Fever patients showed a lower prevalence of mitral annular calcification, indicating potential cardiovascular protection.
Does colchicine reduce the prevalence of mitral annular calcification in patients with Familial Mediterranean Fever?
Colchicine treatment in Familial Mediterranean Fever may offer long-term cardiovascular protection by reducing mitral annular calcification through suppression of chronic inflammation.
Colchicine-treated patients with Familial Mediterranean Fever may be associated with a lower prevalence of mitral annular calcification, suggesting a potential long-term cardiovascular protective effect through suppression of chronic inflammation.
Cüre et al. (2026) studied this question. Colchicine-treated Familial Mediterranean Fever patients showed a lower prevalence of mitral annular calcification, indicating potential cardiovascular protection.